Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

713
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
713
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

4.2K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive Rehabilitation With Adjunctive Bilateral Anodal tDCS in Post-Stroke Dysphagia: A Multicenter Randomized Controlled Trial.

European journal of neurology·2026
Same author

Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants.

medRxiv : the preprint server for health sciences·2026
Same author

Effects of Transcutaneous Spinal Direct Current Stimulation on Cognitive and Psychological Outcomes in Multiple Sclerosis: A Preliminary Case Series.

Biomedicines·2026
Same author

Emotional Training via Telerehabilitation After Surgical Treatment for Facial Palsy: Prospective, Assessor-Blinded, 2-Arm Pilot Cohort Study.

JMIR rehabilitation and assistive technologies·2026
Same author

<i>Roseburia</i>-Associated Gut-Brain Axis Alterations in Relapsing-Remitting Multiple Sclerosis: Evidence from a Household-Matched Case-Control Study.

Nutrients·2026
Same author

Minds and machines: AI's transformative role in human identity and medicine.

Digital health·2026

Related Experiment Video

Updated: Nov 26, 2025

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

11.6K

Cerebrospinal fluid glutamate changes in functional movement disorders.

Benedetta Demartini1,2,3, Roberto William Invernizzi4, Laura Campiglio2

  • 1Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy.

NPJ Parkinson'S Disease
|December 10, 2020
PubMed
Summary

Patients with functional movement disorders (FMDs) have lower cerebrospinal fluid (CSF) glutamate levels compared to controls. This suggests that glutamate dysfunction may play a role in FMD.

More Related Videos

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.9K
Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.4K

Related Experiment Videos

Last Updated: Nov 26, 2025

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

11.6K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.9K
Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.4K

Area of Science:

  • Neuroscience
  • Biochemistry

Background:

  • Functional movement disorders (FMDs) are a group of neurological conditions characterized by abnormal movements.
  • The underlying pathophysiology of FMDs is not fully understood, but neurotransmitter imbalances are suspected.

Purpose of the Study:

  • To investigate cerebrospinal fluid (CSF) amino acid concentrations in patients with FMDs.
  • To compare CSF glutamate levels between FMD patients and healthy controls.

Main Methods:

  • Cerebrospinal fluid (CSF) samples were collected from patients with FMDs and control subjects.
  • Amino acid concentrations, specifically glutamate, were measured using high-performance liquid chromatography (HPLC).

Main Results:

  • CSF glutamate levels were found to be significantly lower in patients with FMDs compared to control individuals.
  • No other specific amino acid differences were detailed in the abstract.

Conclusions:

  • The reduced CSF glutamate levels in FMD patients support the hypothesis of glutamatergic system dysfunction in the disorder's pathophysiology.
  • Further research is warranted to explore the role of glutamate in FMDs.